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which are summarized in chapter 2, emphasize the piv- grappling to devise effective vaccines against the hu-
man immunodeficiency virus (HIV).otal role in shaping HIV molecular epidemiology of multi-
HIV rapidly infects and destroys CD41 T lymphocytes,ple founder effects during HIV migration among host
likely following delivery from peripheral tissues or muco-populations at risk. The nature of HIV variation allows
sal membranes to the secondary lymphoid organs byfor efficacious ways to pose and answer epidemiological
dendritic cells. Vaccine research and development strat-questions, like those concerning the spread of viruses
egies have therefore tended toward bolstering humoralby different transmission routes, within different geneti-
immunity (HI) and/or cell-mediated immunity (CMI) tocally defined risk groups, and in particular ecological
ensure that good defenses are already in line beforeniches.
HIV attempts to breach them (reviewed by Heilman andFor such an excellent book, we miss a section on the
Baltimore, Nat. Med. 4, 532±534, 1998). In general, HIevolutionary history of HIV. The continuing discussion
approaches focus on producing antibody responseson the origin of HIV and HIV subtypes has been heated
that can specifically neutralize viral particles or blockup recently by the discovery of several HIV strains that
their entry into host cells, while CMI approaches focusare unique in terms of their age and/or position in the
on drawing the attention of CD81 cytotoxic T lympho-HIV phylogenetic tree. Although there seems to be no
cytes (CTL) to virally infected cells. A common obstaclefirm consensus on when exactly this virus was intro-
to these approaches has been the unexpected variabilityduced into humans, most researchers agree that the
of HIV epitopes both in the population and arising byhuman virus is relatively ªyoung.º The timescale in the
mutagenesis.midst of this debate is unprecedentedÐfor the first time,
Unfortunately, the roles played by the adaptive im-when talking about the evolutionary origin of a virus,
mune responses (HI and CMI) in the course of HIV infec-we are fighting about decades, not millions of years.
tion remain incompletely, and often inconsistently, de-Researchers are generally optimists, and HIV scientists
fined. We know, for instance, that individuals infectedare no exception: based on longitudinal observation of
with HIV exhibit both of these responses in widely vary-a growing plant, we should be able to estimate its growth
ing degrees throughout the disease course. Not surpris-rate and to trace back in time quite precisely the moment
ingly, infected individuals exhibit extremes of illness:when the seed started to grow. However, what we can-
some succumb rapidly while others advance so slowlynot easily estimate is the age of this seed and how much
(surviving asymptomatically more than 10 years aftertime it spent in the soil after being put there by the
infection) as to be termed long-term nonprogressors.farmer.
Even among infants born to HIV-infected mothers, ac-For the AIDS researchers less versed in HIV molecular
counts have surfaced for identical twins in which onebiology, the Retroviruses textbook, edited by John M.
child progresses rapidly to AIDS while the other childCoffin, Stephen H. Hughes, and Harold E. Varmus (Cold
does not (Goedert, Acta Paediatr. Suppl. 421, 56±59,Spring Harbor Laboratory Press, Plainview, NY, 1997,
1997). Many possibilities have been explored to explainISBN 0±87969±497±1 cloth, ISBN 0±87969±497±1 pa-
phenomena such as these, from differences in certainper), should be kept at hand. All in all, for every re-
chemokine receptors (Liu et al., Cell 86, 367±377, 1996;searcher who is interested in evolution and molecular
Martin et al., Science 282, 1907±1911, 1998) to humanepidemiology of HIV, The Evolution of HIV is the book
leukocyte antigen allotypes expressed among patientsto read.
(Carrington et al., Science 283, 1748±1752, 1999). At
best, they appear to explain some but not all observed
Vladimir V. Lukashov and Jaap Goudsmit immune responses (or lack thereof) to HIV. The clinical
The Department of Human Retrovirology face of AIDS therefore seems nearly as diverse as the
Academic Medical Center viral quasispecies that define the infection of any given
University of Amsterdam individual.
Amsterdam, The Netherlands In light of such inconsistencies, Omar Bagasra con-
tends in his book HIV and Molecular Immunity: Pros-
pects for the AIDS Vaccine that pursuit of vaccines
against HIV is currently advancing with only one eye
open. He argues that ªthe research efforts on retrovi-The HIV X-File
ruses over the past 10±15 years have focused on the
mechanisms of disease production by these pathogens.
HIV and Molecular Immunity: Prospects Now it is time to explore mechanisms by which infected
for the AIDS Vaccine hosts defend themselves. The main postulate of this
By Omar Bagasra book is that evolution has created some sort of intracel-
Natick, MA: Eaton Publishing (1999). 198 pp. $42.95 lular protective mechanism to specifically battle retrovi-
rusesº (p. 5).
Almost two decades ago, four previously healthy individ- Basagra's text is not merely a critique of the trials
uals presenting with mysterious immunodeficiency were and tribulations faced by HIV/AIDS researchers in their
reported (Gottlieb et al., N. Engl. J. Med. 305, 1425±1431, collective quest for answers and, ultimately, a vaccine.
1981). Two years later, international scientists isolated The book is instead a highly personal treatise that de-
a novel retrovirus as the probable cause of an expanding scribes a new theory of immunity based upon (as he
acquired immune deficiency syndrome (AIDS) epidemic admits in the preface, p. x) years of collecting and dis-
(Gallo et al., Science 220, 865±867, 1983; Barre-Sinoussi secting anomalous findings. To be blunt, it is the stuff
of an established scientist's dreams ... and nightmares.et al., Science 220, 868±871, 1983). Today, we are still
Cell
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Throughout, Bagasra reiterates the existence of an Bagasra's results argue that this soluble factor is RNA
as-yet-undescribed ªthird armº of immunity, which he (due to the fact that in vitro protective activity is lost
distinguishes from both HI and CMI, capable of control- when RNase is included in the assays) and that it com-
ling HIV infection at the molecular level. This hypothe- pletely prevents nuclear penetration by HIV (chapter 4).
sized ªmolecular immunityº depends upon expression However, as Brander and Walker appropriately caution
of protective RNAs produced by CD81 T lymphocytes us regarding CTL responses to HIV (Curr. Opin. Immunol.
or natural killer cells that can neutralize viral cDNA prior 11, 451±459, 1999), ªthe relative contributions of cyto-
to nuclear transport and integration. He bases his theory lytic and noncytolytic effector mechanisms in vivo re-
on evidence drawn largely from studies of nonhuman main elusive.º
primates infected with various simian immunodeficiency Overall, HIV and Molecular Immunity: Prospects for
viruses (SIVs); many monkeys infected with strains of the AIDS Vaccine is a well-researched (with more than
SIV that typically infect a different monkey species (and 800 references cited) and bold presentation of a novel
to which the former monkeys have not been previously concept. While most of the support is indirect and non-
exposed) tend to respond similarly as humans infected physiological in nature, anyone with an interest in HIV
with HIV. No disease is demonstrated, however, upon vaccine development will benefit from the detailed his-
infection with the concordant strain, or the virus com- torical accounts and stimulating perspective offered by
mon to a given population of monkeys. Bagasra thus Bagasra in describing his theory of molecular immunity.
builds his idea around an evolutionarily naive state of Although flowing in a much less organized manner than
the susceptible host. This is thought to confer suscepti- the chapters in the table of contents promised (the text
bility to pathogenic infection only in distant host/retrovi- is often as stream-of-consciousness as a chat over cof-
rus combinations. Assuming HIV has arisen from recom- fee in the lunchroom), the book can definitely be recom-
bination events among various SIV strains (the precise mended to the patient reader. Anyone who completes
origins of which remain unknown, though in chapter 2 the it will be strongly persuaded that preventive vaccine
author suggests it occurred during African polio vaccine strategies should aim to barricade viral transcription and
trials), humans therefore serve as ideally naive hosts in integration, while therapeutic vaccination should aim to
which HIV can fully unleash its pathogenic potential. tap the host's innate abilities (if they exist) to control
But why propose an entirely novel arm of immunity to viral replication.
account for protection from HIV infection?: ªThe obvious In any case, the truth is out there ... somewhere. We
reason for the evolution of a different protective mecha- just need to keep both of our eyes open to recognize it.
nism is that retroviruses are genetic parasites that pene-
trate into the host genome much faster than HI or CMI Kiley R. Prilliman
can develop protective barriersº (p. 77). Considering Division of Immune Regulation
this, rapid disease progression might be expected in La Jolla Institute for Allergy and Immunology
100% of clinical cases if antibodies and cytolytic CTL 10355 Science Center Drive
were the only defenses against infection, but we know San Diego, California 92121
that this does not occur. Bagasra discusses at length the
high content of potential retroviral sequence elements
occupying the diverse human genome. He then asserts
that they may have been specifically retained over time,
rather than excised, to play an active role in the immune The Real Millennium Bugs
system (serving as the source of proposed protective
RNAs produced by CTL). Like browsing through a mug Emerging Infections 3
shot book at police headquarters, RNAs transcribed Edited by W. Michael Scheld, William A. Craig,
from these regions might ªrecognizeº (form complexes
and James M. Hughes
with) the genetic material of invading retroviruses such
Washington, D.C.: ASM Press (1999). 258 pp. $79.95as HIV and cripple their abilities to propagate, depending
strongly upon the initial infecting dose. Has this been
Emerging Infections: Biomedical Research Reportsdirectly proven? No, but the theory is certainly not with-
Edited by Richard M. Krauseout appeal.
San Diego, CA: Academic Press (1998). 513 pp. $84.95Despite sounding vaguely like X-Files Agent Fox
Mulder with his proposal, Bagasra's concept does ap-
Infectious diseases have been powerful forces in bothpear to overlap some observations regarding the natural
evolution and human history, as emphasized recentlycontrol of HIV infection aside from conventionally recog-
by Jared Diamond in his book Guns, Germs and Steel:nized HI and CMI contributions. For example, ongoing
The Fates of Human Societies. When the conquistadorsstudies have demonstrated that a soluble CD81 T cell
arrived in Central and South America, they brought withantiviral factor (CAF) can potentially control or even pre-
them their infectious diseases, which had never beforevent infection by HIV (reviewed by Levy et al., Immunol.
been seen in the New World. The resulting epidemicsToday 17, 217±224, 1996; Stranford et al., Proc. Natl.
of smallpox and other infections in an immunologicallyAcad. Sci. USA 96, 1030±1035, 1999). Briefly, the CTL-
naive population devastated the native civilizations andassociated CAF-suppressive effect (1) is observed inde-
ensured the success of the invasion. These are amongpendently of the b-chemokines RANTES, MIP-1a, and
the best-documented historical examples of ªemergingMIP-1b; (2) is not restricted by the major histocompati-
infectionsº and illustrate the spread of disease alongbility complex; and (3) acts at the level of transcription
following viral integration. In conducting similar studies, ocean trade routes. Now, disease can travel even faster,
